“Nose-bleed fever” is as gruesome as it sounds. More technically called Crimean-Congo hemorrhagic fever, the tick-borne virus has been detected in some 120 people in Iraq since January — including 18 who have died from the disease — health officials have warned, fearing an escalating spread.

The onset of illness causes rapid and severe internal and external bleeding in infected patients, including through the nose, hence its nickname “nose-bleed fever.” Though the virus is hosted in ticks, most individuals pick it up by coming in contact with infected animal blood — usually occurring among those who work with livestock and in slaughterhouses.

The virus is not novel, but it is rare — and apparently spreading at an unprecedented rate throughout Iraq. Between 10 and 40 percent of cases will die from the disease. Aside from profuse bleeding and potential death, early symptoms include fever, body aches, dizziness, neck pain, headache, and sore eyes. Nausea, vomiting, diarrhea, sore throat, and brain fog have also been observed in infected patients, according to the World Health Organization.


Advertisement


The virus also called Crimean-Congo hemorrhagic fever, has been known to cause severe symptoms in patients. In some cases, sufferers have reportedly encountered internal and external hemorrhaging, resulting in blood loss. Iraqi officials say that almost one-third of all deaths, thought to be around 18, have come in the last two weeks, sparking fears of an uncontainable outbreak.

According to the World Health Organisation (WHO) patients become infected with the virus following contact with the blood of infected animals, including ticks. The virus is not novel, but it is rare and apparently spreading at an unprecedented rate throughout Iraq.

Between 10 and 40 percent of cases die from the disease. Aside from profuse bleeding and potential death, early symptoms include fever, body aches, dizziness, neck pain, headache, and sore eyes. Nausea, vomiting, diarrhea, sore throat, and brain fog have also been observed in infected patients, according to the World Health Organization.